Αποτελέσματα Αναζήτησης
6 Μαρ 2024 · A once-daily oral combination therapy for HIV — bictegravir plus lenacapavir — is more effective than complex regimens are, according to results from a phase 2 study of people with HIV who are virologically suppressed, presented the Conference on Retrovirus and Opportunistic Infections (CROI) in Denver.
4 Ιαν 2023 · Sunlenca is the first of a new class of drugs called capsid inhibitors to be FDA-approved for treating HIV-1. Sunlenca works by blocking the HIV-1 virus’ protein shell (the capsid), thereby interfering with multiple essential steps of the viral lifecycle.
18 Οκτ 2024 · Overall, the benefits of FDA-approved HIV medicines far outweigh the risk of side effects. In addition, HIV medicines have been improved over the years to cause fewer side effects, making people less likely to have side effects from HIV medicines.
31 Ιουλ 2024 · The following table lists HIV medicines recommended for the treatment of HIV infection in the United States, based on the U.S. Department of Health and Human Services (HHS) HIV and AIDS medical practice guidelines. All of these drugs are approved by the U.S. Food and Drug Administration (FDA).
18 Νοε 2021 · Thousands of people with HIV will now be offered a new long-acting injection to manage their condition if they would prefer to stop taking daily pills. Charities have welcomed the approval of the...
Side effects occurring more frequently in participants who received Apretude compared to participants who received Truvada in either trial include injection site reactions, headache, pyrexia...
9 Νοε 2023 · Several open-label studies have evaluated different regimens containing INSTIs in conjunction with nucleoside reverse transcriptase inhibitors for PEP. Raltegravir-based regimens have been generally well tolerated with mild side-effects, the most notable being musculoskeletal symptoms.